In addition, one of the major checkpoint pathways represents a tumor-induced immunosuppressive milieu mediated by the PD-1/PD-L1 axis of high PD-1 expression on activated T cells interacting with PD-L1 on tumor cells [40]. The gene discussed is PDCD1; the disease is neoplasm.